Quantcast
Last updated on April 25, 2014 at 5:51 EDT

Latest Avandia Stories

2009-06-05 16:15:00

RECORD trial also demonstrates durable blood sugar control over time with Avandia LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 5 /PRNewswire/ -- Clinical trial results presented today at the American Diabetes Association annual meeting show that overall rates of cardiovascular hospitalization and cardiovascular death are similar in patients taking Avandia (rosiglitazone) compared to those receiving metformin and sulfonylurea. Results from the 4,447-patient Rosiglitazone...

2009-06-05 07:00:00

Today's announcement hurts thousands of Avandia patients, counsel says HOUSTON, June 5 /PRNewswire/ -- Noted Houston trial lawyer Mark Lanier of The Lanier Law Firm says "useless trick science" is the basis for a new study being unveiled today in New Orleans by drug maker GlaxoSmithKline (NYSE: GSK) about the side effects caused by the company's diabetes medication Avandia, which reportedly has been linked to heart problems in thousands of patients. Mr. Lanier represents many former Avandia...

2009-05-15 09:45:00

- Welchol Added to Metformin Significantly Reduced A1C and LDL-C in Patients with Type 2 Diabetes - Open-Label Extension Study Demonstrated the Safety and Durability of Welchol for up to 78 Weeks of Treatment PARSIPPANY, N.J., May 15 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced today that data from a 16-week, randomized, open-label pilot study demonstrated that Welchol(R) (colesevelam HCl) significantly improved glycemic control and reduced mean LDL cholesterol (LDL-C) when added to...

986a558158ef4592eeff82e60a9c12d91
2008-12-10 14:20:00

A study released on Wednesday shows that long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes. The two thiazolidinedione (TZD) drugs for diabetes were known for some time to be associated with fractures, but the magnitude of the risk had not been evaluated until now. "Women with type 2 diabetes are already at an increased risk of fractures, so any additional risk from thiazolidinedione therapy could have a considerable...

a7fe3f28bdf764e7b102c35b2d8d45c81
2008-11-13 09:05:00

New findings support the claim that a controversial diabetes pill failed to significantly slow plaque buildup in heart arteries compared with an older drug. Since May of last year, Avandia, once a blockbuster drug made by British-based GlaxoSmithKline PLC, has been under a dark cloud of doubt. That's because a medical journal report suggested it could raise the risk of heart attacks and heart-related deaths; the American Diabetes Association recently said patients should avoid using it...

fdb89ddb7463ca2d19cb071d800f784a1
2008-10-31 10:30:00

Public Citizen, a consumer advocate group, has called on the U.S. to ban sales and distribution of the diabetes drug Avandia due to certain risks found to be linked with the drug. New research released by Public Citizen about the drug, used to treat Type 2 diabetes, comes as a working group with representatives from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes, unanimously advised against using Avandia, whose generic name is rosiglitazone,...

2008-10-30 21:00:11

PHILADELPHIA, Oct. 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline today issued the following response to a petition filed by Public Citizen to the U.S. Food and Drug Administration (FDA) on AVANDIA(R) (rosiglitazone maleate), a highly effective therapy for treating type 2 diabetes when used in the appropriate patient population. The safety of patients using our medicine is very important to us. On a continual basis, an external Hepatic Safety Board reviews any adverse event report received...

4c3eb47c3955711dbdd964a2c153b62d1
2008-10-28 08:40:00

Treatment for diabetic Americans has doubled in cost during the past six years. Last year, the bill hit an eye-popping $12.5 billion.Researchers said new, pricey drugs are driving the increase, despite a lack of evidence for the new drugs' greater benefits and safety. The study follows updated treatment advice for Type 2 diabetes that was issued last week.In the recommendations, an expert panel told doctors to use older, cheaper drugs first.Another study points to evidence that metformin, an...

2008-08-13 15:01:02

A wrongful death suit was filed against GlaxoSmithKline, SmithKline Beecham, and McKesson Corporation in California Superior Court, charging that Avandia, prescribed for Type 2 Diabetes, led to heart attacks, congestive heart failure and other fatal cardiovascular injuries in seven individuals. The suit, brought by Khorrami, Pollard & Abir and Kabateck Brown Kellner, LLP, was filed on behalf of the victims' seven surviving spouses, including Los Angeles, CA, and Costa Mesa, CA,...

2008-07-14 09:00:14

PHILADELPHIA, July 14 /PRNewswire-FirstCall/ -- GlaxoSmithKline announces today that the U.S. Food and Drug Administration (FDA) updated the prescribing information for AVANDIA(R) (rosiglitazone maleate) to include clinical findings from A Diabetes Outcome Progression Trial (ADOPT), a 4- to- 6 year head-to-head study of AVANDIA versus metformin and glyburide monotherapy in recently diagnosed type 2 diabetes patients. The percentage of patients with inadequate glucose control at five years...